Venn Life Sciences has launched InnoVenn, a new innovation division set up to focus on co-development opportunities, particularly for medical devices. The goal of InnoVenn is to accelerate the commercialization of products in the later stages of development. Its first co-development initiative will be a joint venture with Cellulac Ltd. and Biopharmed West Ltd. to develop next generation biodegradable human implants to replace the widespread use of titanium in orthopedic surgery. Venn will provid...